Delivery Order SPE2DE21D0005-SPE2D625F1CTU
Award Date 8/15/25
Potential Completion Date 8/20/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $5,790.00 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract is for PURAPLY AM XT 4.91X4.91, an advanced wound care dressing used for surgical and wound treatment applications. The award utilized fixed-price pricing with economic price adjustment provisions and was not designated as a...
- Organogenesis Inc. was awarded a $8,500 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by July 28, 2025. The work will be performed at Organogenesis' headquarters in Canton, Massachusetts. No set-aside designation was utilized for this award, indicating...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $2,088.00 for PURAPLY Micronized, 500mg on July 31, 2025, with an ultimate completion date of August 5, 2025. This fixed-price contract with economic price adjustment was awarded without set-aside designation by the Defense Logistics Agency's Medical Supply Chain division. PURAPLY Micronized is an advanced wound care product utilized in regenerative medicine...
- This federal contract award was made by the Medical Supply Chain division of the U.S. Defense Department to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $5,100 fixed-price delivery order, awarded on May 12, 2025, is for PURAPLY AM XT 4.91x4.91 wound dressings with an ultimate completion date of May 15, 2025. The contract does not utilize a set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis holds...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $8,500 delivery order to Organogenesis Inc. on August 4, 2025, for PURAPLY AM XT EF 5-layer fenestrated wound care dressing. The contract is fixed-price with economic price adjustment and carries an ultimate completion date of August 7, 2025. The award was made without a set-aside designation, allowing Organogenesis to compete as a standard commercial vendor. Performance will take place at the company's headquarters in...
- The U.S. government awarded a $3,400.00 fixed-price delivery order contract to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is for the supply of PURAPLY AM XT EF, a 5-layer fenestrated wound dressing product, with a performance period ending on July 3, 2025. This award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and is not a set-aside contract. Organogenesis is a manufacturer of advanced wound care,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17.82K delivery order to Organogenesis Inc. on August 11, 2025, for PURAPLY SX 6CM X 9CM wound care products, with an ultimate completion date of August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, allowing Organogenesis to compete as a standard commercial vendor. Performance will occur at the contractor's headquarters in Canton,...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,274.00 to Organogenesis Inc. for the supply of PURAPLY Micronized 500mg, an advanced wound care product. The contract, awarded on July 23, 2025, with an ultimate completion date of July 28, 2025, utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. Organogenesis, a regenerative medicine company headquartered in Canton, Massachusetts, will perform the...
- This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, to provide PURAPLY AM wound dressings to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,678.32 fixed-price with economic price adjustment delivery order has a period of performance through June 16, 2025. Organogenesis is an established supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies,...
- This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine manufacturer based in Canton, Massachusetts. The contract is a delivery order for PURAPLY AM XT 4.91X4.91 wound dressings, which are used for advanced wound care. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and the DLA, including a $25 million...